Services Promacta Tablet Supplier

Promacta Tablet Supplier

Derek Clarke is a trusted Promacta tablet supplier.


Promacta (eltrombopag, GlaxoSmithKline) is indicated for:


  • Treatment of low blood platelet counts in people with chronic immune (Idiopathic) thrombocytopenia, when either corticosteroids, immunoglobulins or surgery to remove the spleen have not worked well enough.
  • Treatment of low blood platelet counts in people with chronic hepatitis C virus (HCV) infection before and during treatment with interferon.

In 2014, Promacta was also approved for use in patients with severe aplastic anaemia (SAA) who have had an insufficient response to immunosuppressive therapy. SAA is a blood disorder where the bone marrow fails to make enough red blood cells, white blood cells, and platelets. The drug helps to increase the production of blood cells by inducing proliferation and differentiation of bone marrow stem cells.

Please contact the manufacturer for safety information about Promacta.

Derek Clarke, with more than 30 years as experience as an exporter of both branded and generics medicines, is able to source and supply products, often unavailable through other sources, quickly and efficiently.

For more information about Derek Clarke as a Promacta tablet supplier please contact us on

+44 (0) 208 952 2061